Skip to main content
Pharmanutra logo

Pharmanutra — Investor Relations & Filings

Ticker · PHN ISIN · IT0005274094 LEI · 815600F8217BC7733697 XMIL Manufacturing
Open in API
Filings indexed 601 across all filing types
Latest filing 2024-03-15 Proxy Solicitation & In…
Country IT Italy
Listing XMIL PHN

About Pharmanutra

http://www.pharmanutra.it

PharmaNutra is a company operating in the pharmaceutical and nutraceutical sectors, focused on the development and distribution of nutritional supplements and medical devices. Grounded in scientific research, the company creates innovative solutions for health and wellness. Its core activities center on addressing nutritional deficiencies, particularly iron, through proprietary functional ingredients and technologies. The product portfolio also extends to supporting muscle and joint health, sports nutrition, and applications across various therapeutic areas, including gynecology, orthopedics, hematology, and gastroenterology. The company emphasizes the development of effective and safe products supported by clinical evidence.

Recent filings

Filing Released Lang Actions
Relazione illustrativa incremento compenso Collegio Sindacale
Proxy Solicitation & Information Statement Classification · 1% confidence The document is titled "RELAZIONE ILLUSTRATIVA DEL CONSIGLIO DI AMMINISTRAZIONE SULLE MATERIE ALL'ORDINE DEL GIORNO DELL'ASSEMBLEA ORDINARIA DI PHARMANUTRA S.P.A." (Explanatory Report of the Board of Directors on the items on the agenda of the Ordinary General Meeting of PharmaNutra S.p.A.). It specifically discusses a proposal regarding the remuneration ('remunerazione') of the Board of Statutory Auditors ('Collegio Sindacale') to be voted upon at the upcoming AGM. This content directly relates to the information provided to shareholders to inform their vote, which aligns with the definition of Proxy Solicitation & Information Statement (PSI). While it touches upon remuneration (DEF 14A), the primary context is the explanatory report supporting a resolution for the General Meeting, making PSI the most accurate fit for the overall document type, as it is a document soliciting shareholder action/information ahead of a meeting. It is not the final voting result (DVA) nor the full remuneration report (DEF 14A), but the explanatory material for a resolution.
2024-03-15 Italian
Relazione illustrativa incremento del compenso fisso complessivo annuo attribuito al Consiglio di Amministrazione
AGM Information Classification · 1% confidence The document is titled "RELAZIONE ILLUSTRATIVA DEL CONSIGLIO DI AMMINISTRAZIONE SULLE MATERIE ALL'ORDINE DEL GIORNO DELL'ASSEMBLEA ORDINARIA DI PHARMANUTRA S.P.A." (Explanatory Report of the Board of Directors on the Matters on the Agenda of the Ordinary General Meeting of PharmaNutra S.p.A.). It specifically discusses a proposal regarding the increase of the fixed annual compensation for the Board of Directors, which is a key item typically presented to shareholders for approval at an Annual General Meeting (AGM). Furthermore, the text explicitly mentions the 'Relazione sulla politica in materia di remunerazione e sui compensi corrisposti' (Report on remuneration policy and compensation paid), which is directly related to director compensation, often covered in proxy statements or AGM materials. Since the document is the explanatory report for matters to be voted on at the AGM, and one of the main topics is director remuneration, it strongly aligns with materials presented during or in preparation for an AGM. Given the options, 'AGM-R' (AGM Information) is the most appropriate classification for the explanatory report detailing proposals for shareholder vote at the AGM.
2024-03-15 Italian
Explanatory memorandum on remuneration policy and remuneration paid
Remuneration Information Classification · 1% confidence The document is explicitly titled as a "BOARD OF DIRECTORS' MEMORANDUM ON THE ITEMS ON THE AGENDA OF THE ORDINARY SHAREHOLDERS' MEETING" and focuses entirely on Item 2: "Report on remuneration policy and remuneration paid." It details the structure of the Remuneration Report (Section I and Section II) and presents proposed resolutions for shareholder approval regarding this report, referencing Italian Legislative Decree no. 58/1998 (Consolidated Law on Finance) and CONSOB regulations. The content directly addresses the remuneration policy and compensation paid to directors and statutory auditors, which aligns perfectly with the definition of Remuneration Information (DEF 14A). Although it is a memorandum presented for an AGM, the core subject matter is the remuneration report itself, making DEF 14A the most specific classification over AGM-R (which is for presentations/materials) or PSI (which is for proxy solicitation/information statements requesting votes, though this document is related to the meeting, its primary content is the remuneration details).
2024-03-15 English
NOTICE CALLING THE ORDINARY GENERAL MEETING OF SHAREHOLDERS
AGM Information Classification · 1% confidence The document is explicitly titled "NOTICE CALLING THE ORDINARY GENERAL MEETING OF SHAREHOLDERS OF PHARMANUTRA S.P.A." and details the date, time, location (virtual participation method), and the full AGENDA for the meeting. The agenda items include approval of financial statements, remuneration policy, and authorization for treasury share purchases. This content is characteristic of a formal notice convening a shareholder meeting, which aligns directly with the definition of AGM Information (AGM-R). While it mentions financial statements (10-K/IR items), the primary purpose and format are the call notice itself.
2024-03-15 English
AVVISO DI CONVOCAZIONE ASSEMBLEA ORDINARIA
AGM Information Classification · 1% confidence The document is titled "AVVISO DI CONVOCAZIONE DI ASSEMBLEA ORDINARIA" (Notice of Call for Ordinary General Meeting) for Pharmanutra S.p.A. It details the date (April 16, 2024), location, and crucially, the 'ORDINE DEL GIORNO' (Agenda). The agenda items include the approval of the 2023 Financial Statements, remuneration policy, and authorization for share buybacks. Furthermore, it extensively covers the procedures for shareholder participation, voting rights, proxy designation (Rappresentante Designato), and the right to submit questions or integrate the agenda, all typical components of a formal meeting notice. This document serves to formally convene shareholders for a meeting, which aligns perfectly with the definition of AGM Information (AGM-R), which covers presentations and materials shared during the AGM. While it discusses the financial statements (10-K/IR items), the document itself is the *notice* of the meeting where these items will be voted upon, making AGM-R the most precise classification.
2024-03-15 Italian
Relazione illustrativa sulla politica in materia di remunerazione e sui compensi corrisposti
Remuneration Information Classification · 1% confidence The document is titled "RELAZIONE ILLUSTRATIVA DEL CONSIGLIO DI AMMINISTRAZIONE SULLE MATERIE ALL'ORDINE DEL GIORNO DELL'ASSEMBLEA ORDINARIA" (Explanatory Report of the Board of Directors on the Agenda Items of the Ordinary Shareholders' Meeting). Specifically, it focuses on Agenda Item No. 2: "Relazione sulla politica in materia di remunerazione e sui compensi corrisposti" (Report on remuneration policy and compensation paid), referencing Italian legislative decrees (D.Lgs. n. 58/1998, art. 123-ter) which govern the disclosure of remuneration reports presented to shareholders for approval (binding or non-binding vote). This content directly corresponds to the disclosure requirements for executive and director compensation, which aligns with the definition for Remuneration Information (DEF 14A), even though the document is an Italian explanatory report rather than the specific SEC form name. The core subject matter is remuneration policy and compensation details presented ahead of a shareholder vote.
2024-03-15 Italian

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.